EDGAR Filing Documents for 0001558370-22-001932

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-22-001932

Filing Date

2022-02-24

Accepted

2022-02-24 16:16:09

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	knsa-20211231x10k.htm iXBRL	10-K	3318951
2	EX-10.33	knsa-20211231xex10d33.htm	EX-10.33	186325
3	EX-10.34	knsa-20211231xex10d34.htm	EX-10.34	480133
4	EX-10.35	knsa-20211231xex10d35.htm	EX-10.35	22523
5	EX-10.36	knsa-20211231xex10d36.htm	EX-10.36	319446
6	EX-10.37	knsa-20211231xex10d37.htm	EX-10.37	180566
7	EX-10.38	knsa-20211231xex10d38.htm	EX-10.38	720093
8	EX-23.1	knsa-20211231xex23d1.htm	EX-23.1	1965
9	EX-31.1	knsa-20211231xex31d1.htm	EX-31.1	14184
10	EX-31.2	knsa-20211231xex31d2.htm	EX-31.2	14128
11	EX-32.1	knsa-20211231xex32d1.htm	EX-32.1	7694
12	EX-32.2	knsa-20211231xex32d2.htm	EX-32.2	7608
13	GRAPHIC	knsa-20211231x10k006.jpg	GRAPHIC	34923
14	GRAPHIC	knsa-20211231x10k008.jpg	GRAPHIC	47620
15	GRAPHIC	knsa-20211231xex10d35001.jpg	GRAPHIC	7481
16	GRAPHIC	knsa-20211231xex10d36001.jpg	GRAPHIC	651
17	GRAPHIC	knsa-20211231xex10d37001.jpg	GRAPHIC	6800
	Complete submission text file	0001558370-22-001932.txt		13827432

Data Files

Seq	Description	Document	Type	Size
18	EX-101.SCH	knsa-20211231.xsd	EX-101.SCH	71596
19	EX-101.CAL	knsa-20211231_cal.xml	EX-101.CAL	77210
20	EX-101.DEF	knsa-20211231_def.xml	EX-101.DEF	324075
21	EX-101.LAB	knsa-20211231_lab.xml	EX-101.LAB	657324
22	EX-101.PRE	knsa-20211231_pre.xml	EX-101.PRE	510130
92	EXTRACTED XBRL INSTANCE DOCUMENT	knsa-20211231x10k_htm.xml	XML	1919960

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11

Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100

Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)